FREDERICK, Md., Dec. 9, 2013 /PRNewswire/ -- BioElectronics
Corporation (OTC Pink: BIEL), the maker of advanced consumer pain
management medical devices, today announced that Boots
(www.boots.com), the UK's premier health and beauty retailer, is
selling its ActiPatch® Pain Therapy products in its
select stores for back, knee and musculoskeletal
ailments.
Paul Screawn, Director of
GRO-International, European Brand Managers, said
"ActiPatch® brings real innovation to both consumers
and customers. The innovation and the consumer benefits of long
lasting, safe and affordable pain relief gained the interest of the
Boots team. Their input and guidance has been invaluable in
ensuring the Brand is relevantly positioned to grow in the UK and
broader European markets. We are looking forward to working
together to safely relieve pain, inflammation, and accelerate
healing at affordable prices on current and our pipeline of new
products."
About Alliance Boots
Boots is a leading pharmacy group
in the United Kingdom, part of the
Boots Alliance in more than 25 countries, and is a strategic
partner with Walgreens Co., the largest drugstore chain in
the United States.
For more information, please contact the Boots UK Press Office
on 020 7025 6657 or bootshealthteam@redconsultancy.com.
About BioElectronics Corporation
BioElectronics
Corporation is the maker of disposable, drug-free, pain therapy
medical devices. ActiPatch® Therapy,
over-the-counter treatment for back pain and other musculoskeletal
complaints; RecoveryRx® Devices for chronic and
post-operative wound care; and the Allay® Menstrual
Pain Therapy.
Please visit www.bielcorp.com for more information.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation